Sunday, 14 December, 2025
Inito Secures $29M to Advance AI-Powered At-Home Diagnostics
At-home diagnostics firm Inito raised $29 million in Series B funding, led by Bertelsmann India Investments. The capital will fuel expansion beyond its successful fertility monitor to a broader health diagnostics platform. Inito plans to develop new clinical-grade tests for hormones and vitamins using synthetic, AI-engineered antibodies, moving away from slow, traditional, animal-based methods.
Read full story at Ascendants